miR-26b decreased MIEN1 levels in non-small-cell lung cancer cells, which downregulated the metastasis activity via the NF-κB/MMP-9/VEGF (vascular endothelial growth factor) pathways [7]. The gene discussed is MIEN1; the disease is non-small cell lung carcinoma.